ISIS-DMPKRx

ISIS-DMPKRx · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-DMPKRx, covering 2022-12-06 to 2022-12-06. Get the full timeline:

Most recent: Clinical Trial Update: A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 [Phase 1, Phase 2]

See pricing